3-year-old Durham startup chases Covid-19 treatment with $100M
September 19, 2021 at 18:25 PM EDT
The Durham company is committing $100 million to advance a combination therapy aimed at treating Covid-19 following positive results from a trial sponsored by the National Institutes of Health.
